Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
liver
82%
apolipoproteins
79%
lipoproteins
77%
triglycerides
68%
chylomicrons
58%
metabolism
54%
density
51%
kinetics
40%
patients
36%
comparative evaluations
35%
diseases
30%
diffusion
30%
therapy
29%
transport
29%
histology
28%
spectroscopy
27%
niacin
25%
juveniles
25%
dehydrogenases
25%
humans
25%
phospholipids
25%
fibrosis
25%
hydrogen 1
25%
kidneys
25%
failures
25%
metastases
25%
adults
25%
cancer
25%
nmr imaging
25%
conversion
25%
fats
23%
range
22%
microstructure
20%
carriers
18%
plasma
17%
genes
15%
particles
15%
secretion
14%
insulin
13%
sensitivity
13%
data
12%
production
12%
control
11%
values
11%
levels
10%
clearance
10%
risks
10%
anisotropy
10%
losses
10%
atrophy
10%
Biochemistry, Genetics and Molecular Biology
Triglyceride
100%
Maturity Onset Diabetes of the Young
60%
Metabolic Pathway
56%
Chylomicron
54%
Apolipoprotein
53%
Very Low-Density Lipoprotein
41%
Lipogenesis
37%
Triglyceride-Rich Lipoprotein
34%
Insulin Resistance
34%
Liraglutide
31%
Dyslipidemia
28%
Lipoprotein
27%
Mitochondrial Myopathy
25%
Muscle Function
25%
Hydroxysteroid Dehydrogenase
25%
Genetic Risk
25%
Evolocumab
25%
Apolipoprotein C3
25%
Niacin
25%
Mitochondrial Respiration
25%
Polyunsaturated Fatty Acid
25%
Patatin-Like Phospholipase
25%
Homo sapiens
25%
Deficiency
25%
Phospholipid
25%
Lipolysis
22%
Insulin Sensitivity
21%
Glucose
19%
Genetics
18%
Low-Density Lipoprotein
18%
Blood Plasma
17%
Nuclear Magnetic Resonance Spectroscopy
13%
Secretion (Process)
13%
Amino Acids
12%
Glycerol
12%
Lipid
12%
Triacylglycerol Blood Level
11%
Intermediate-Density Lipoprotein
10%
Lecithin
10%
Saturated Fatty Acids
10%
Ketogenesis
10%
Allele
9%
Enzymatic Hydrolysis
8%
Mitochondrial Biogenesis
8%
Muscle Strength
8%
Metabolome
8%
Metabolite
8%
Nicotinamide
8%
Homozygote
7%
Diacylglycerol
7%
Keyphrases
Niacin
25%
NAD+ Deficiency
25%
Adult-onset
25%
Mitochondrial Myopathy
25%
Muscle Performance
25%
PNPLA3
25%
I148M
25%
Non-carriers
25%
Juvenile Neuronal Ceroid Lipofuscinosis
25%
Apolipoprotein B-48
25%
Hypertriglyceridemia
25%
Hepatic Steatosis
25%
Hydroxysteroid
25%
Ketogenic Diet
25%
Hepatic Mitochondria
25%
Apolipoprotein C-III (ApoC-III)
25%
Diabetic Dyslipidemia
25%
Function Status
25%
Evolocumab
25%
Catheter-related Bloodstream Infection (CRBSI)
25%
Postprandial Kinetics
25%
Metabolic Dysfunction
25%
Liver Status
25%
Intestinal Failure
25%
Neoadjuvant Therapy
25%
Conversion Therapy
25%
Prospective multicenter
25%
Systemic Therapy
25%
ApoB48
22%
Hepatic Fat
21%
HSD17B13
18%
De Novo Lipogenesis
18%
Adipocyte Lipolysis
18%
Parenteral Support
16%
Gene Variants
12%
Hepatic Insulin Sensitivity
12%
Steatosis
12%
Inflammatory Genes
12%
Intermediate-density Lipoprotein
10%
White Matter Microstructure
10%
Metabolic Components
9%
Hepatic Insulin Resistance
8%
Ketogenesis
8%
Homozygote
7%
Diacylglycerol
7%
Liver Metastasis
7%
5-year Survival
7%
Liver Histology
6%
Cirrhosis
6%
Hepatic Fatty Acids
6%